Leerink Partners analyst, Seamus Fernandez, reiterated his Market Perform rating on shares of AstraZeneca (NYSE: AZN) and raised his price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE